UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

Phase 2

Withdrawn

Conditions: Prostate Adenocarcinoma

Interventions: Combination Product: MVA-BN-Brachyury

First Posted Date: 2019-07-15

Last Posted Date: 2021-09-22

Lead Sponsor: University of Utah

Registration Number: NCT04020094

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery

Phase 4

Completed

Conditions: Opioid Use

Interventions: Drug: Celecoxib
Drug: Percocet
Drug: Acetaminophen
Drug: Pregabalin
Drug: Oxycodone

First Posted Date: 2019-07-11

Last Posted Date: 2024-07-08

Lead Sponsor: University of Utah

Target Recruit Count: 100

Registration Number: NCT04015908

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Microbial Sampling of Carious Dentin

Withdrawn

Conditions: Caries,Dental

First Posted Date: 2019-07-08

Last Posted Date: 2023-05-10

Lead Sponsor: University of Utah

Registration Number: NCT04011605

Locations: 🇺🇸
University of Utah School of Dentistry, Salt Lake City, Utah, United States

Reconfiguring the Patient Room to Increase Patient Stability

Not Applicable

Recruiting

Conditions: Accidental Falls
Hospitals
Elderly, Frail

Interventions: Other: Room configuration

First Posted Date: 2019-07-01

Last Posted Date: 2023-11-08

Lead Sponsor: University of Utah

Target Recruit Count: 25

Registration Number: NCT04003779

Locations: 🇺🇸
Dumke Health Professions Building, Salt Lake City, Utah, United States

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

Phase 4

Withdrawn

Conditions: Pulmonary Embolism
Deep Venous Thrombosis
Venous Thromboembolism
Bleeding as Surgical Complication (Treatment)

Interventions: Drug: Receipt of enoxaparin
Drug: Placebo

First Posted Date: 2019-06-17

Last Posted Date: 2021-10-08

Lead Sponsor: University of Utah

Registration Number: NCT03988231

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

Early Phase 1

Recruiting

Conditions: Fatigue
Metastatic Prostate Carcinoma
Sedentary Lifestyle
Stage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8
Stage IVA Prostate Cancer AJCC (American Joint Committee on Cancer) v8
Stage IVB Prostate Cancer AJCC (American Joint Committee on Cancer) v8

Interventions: Behavioral: Exercise Intervention
Dietary Supplement: Creatine Monohydrate
Other: Questionnaire Administration

First Posted Date: 2019-06-14

Last Posted Date: 2024-04-11

Lead Sponsor: University of Utah

Target Recruit Count: 100

Registration Number: NCT03987217

Locations: 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

Broadening the Reach, Impact, and Delivery of Genetic Services

Not Applicable

Completed

Conditions: Risk Reduction Behavior
Cancer

Interventions: Other: Patient Directed Standard of Care

First Posted Date: 2019-06-14

Last Posted Date: 2025-01-08

Lead Sponsor: University of Utah

Target Recruit Count: 3073

Registration Number: NCT03985852

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States

Risk Information and Skin-cancer Education for Undergraduate Prevention

Not Applicable

Completed

Conditions: Young Adult
Melanoma

Interventions: Other: Skin Cancer Education
Diagnostic Test: MC1R Genetic Testing
Device: UV Photo

First Posted Date: 2019-06-07

Last Posted Date: 2021-07-13

Lead Sponsor: University of Utah

Target Recruit Count: 92

Registration Number: NCT03979872

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Effects of Fixation Technique On Thoracic Epidural Catheter Displacement

Not Applicable

Recruiting

Conditions: Thoracic Epidural

Interventions: Other: Thoracic Epidural Catheter Fixation Techniques

First Posted Date: 2019-06-05

Last Posted Date: 2023-11-09

Lead Sponsor: University of Utah

Target Recruit Count: 300

Registration Number: NCT03976154

Locations: 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States

CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia

Early Phase 1

Terminated

Conditions: CALR Gene Mutation
JAK2 Gene Mutation
Obstructive Sleep Apnea Syndrome
MPL Gene Mutation
Essential Thrombocythemia
Polycythemia Vera

Interventions: Other: Patient Observation
Procedure: Continuous Positive Airway Pressure
Other: Questionnaire Administration

First Posted Date: 2019-06-04

Last Posted Date: 2024-01-08

Lead Sponsor: University of Utah

Target Recruit Count: 8

Registration Number: NCT03972943

Locations: 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
🇺🇸
Veterans Administration Medical Center, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy